Vaccine maker Novavax Inc said on Monday it has pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks instead of November.
Trending:
Novavax delays U.S. COVID-19 vaccine trial again, now sees start in the coming weeks